Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

340 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Development of Skin Rash Predicts Outcome of Anti-PD-1- and Anti-CTLA4-Based Immune Checkpoint Inhibitor Therapy in Non-Small Cell Lung Cancer or Squamous Cell Carcinoma of the Head and Neck: A Single-Center Analysis.
Mayer K, Briese W, Blieninger J, Brossart P, Bisht S, Feldmann G. Mayer K, et al. Among authors: brossart p. Oncol Res Treat. 2021;44(10):538-546. doi: 10.1159/000518449. Epub 2021 Aug 19. Oncol Res Treat. 2021. PMID: 34515189 Free article.
Everolimus for the treatment of pancreatic neuroendocrine tumors.
Feldmann G, Bisht S, Schütte U, Haarmann J, Brossart P. Feldmann G, et al. Among authors: brossart p. Expert Opin Pharmacother. 2012 Oct;13(14):2073-84. doi: 10.1517/14656566.2012.713348. Epub 2012 Aug 8. Expert Opin Pharmacother. 2012. PMID: 22873789 Review.
Inactivation of Brca2 cooperates with Trp53(R172H) to induce invasive pancreatic ductal adenocarcinomas in mice: a mouse model of familial pancreatic cancer.
Feldmann G, Karikari C, dal Molin M, Duringer S, Volkmann P, Bartsch DK, Bisht S, Koorstra JB, Brossart P, Maitra A, Fendrich V. Feldmann G, et al. Among authors: brossart p. Cancer Biol Ther. 2011 Jun 1;11(11):959-68. doi: 10.4161/cbt.11.11.15534. Epub 2011 Jun 1. Cancer Biol Ther. 2011. PMID: 21455033 Free PMC article.
Cyclin-dependent kinase inhibitor Dinaciclib (SCH727965) inhibits pancreatic cancer growth and progression in murine xenograft models.
Feldmann G, Mishra A, Bisht S, Karikari C, Garrido-Laguna I, Rasheed Z, Ottenhof NA, Dadon T, Alvarez H, Fendrich V, Rajeshkumar NV, Matsui W, Brossart P, Hidalgo M, Bannerji R, Maitra A, Nelkin BD. Feldmann G, et al. Among authors: brossart p. Cancer Biol Ther. 2011 Oct 1;12(7):598-609. doi: 10.4161/cbt.12.7.16475. Epub 2011 Oct 1. Cancer Biol Ther. 2011. PMID: 21768779 Free PMC article.
340 results